Advertisement

Research Article Free access | 10.1172/JCI112674

T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.

J F Moreau, M Bonneville, M A Peyrat, A Godard, Y Jacques, C Desgranges, and J P Soulillou

Find articles by Moreau, J. in: JCI | PubMed | Google Scholar

Find articles by Bonneville, M. in: JCI | PubMed | Google Scholar

Find articles by Peyrat, M. in: JCI | PubMed | Google Scholar

Find articles by Godard, A. in: JCI | PubMed | Google Scholar

Find articles by Jacques, Y. in: JCI | PubMed | Google Scholar

Find articles by Desgranges, C. in: JCI | PubMed | Google Scholar

Find articles by Soulillou, J. in: JCI | PubMed | Google Scholar

Published October 1, 1986 - More info

Published in Volume 78, Issue 4 on October 1, 1986
J Clin Invest. 1986;78(4):874–879. https://doi.org/10.1172/JCI112674.
© 1986 The American Society for Clinical Investigation
Published October 1, 1986 - Version history
View PDF
Abstract

Mechanically harvested lymphocytes invading an irreversibly rejected human kidney allograft were seeded at limiting dilution to calculate the frequency of growing precursors. Optimal growth frequency (1/13) was obtained when Epstein-Barr virus (EBV)-transformed donor B lymphocytes were used as stimulators (D-BLCL) in the presence of interleukin 2 (IL-2). The 55 clones analyzed were all T11+ and T3+, and all expressed DR antigens (45% were T8+ and 55% T4+). Only one clone had a double-labeled (T4+ T8+) surface. All cells proliferated significantly against D-BLCL, although T4+ clones had a significantly shorter average doubling time than T8+ clones. Nearly all T8+ clones were specifically cytotoxic for D-BLCL, while both T4 and T8 did not react against K562, autologous EBV-BLCL, and third-party EBV-BLCL. Detectable IL-2 was found in the culture supernatants of only a minority of clones (all T4+).

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (October 1, 1986): No description
Advertisement
Advertisement